Liposomal adjuvant compositions for epstein barr virus vaccines

TW202639159APending Publication Date: 2026-10-01MERCK SHARP & DOHME CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114148337
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-12
Filing Date
2025-12-10
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078744_001
    Figure TWG2TA001078744_001
  • Figure TWG2TA001078744_002
    Figure TWG2TA001078744_002
  • Figure TWG2TA001078744_003
    Figure TWG2TA001078744_003
Patent Text Reader

Abstract

The present disclosure provides a vaccine composition that comprises an Epstein Barr Virus (EBV) polypeptide and a liposomal adjuvant, and methods of inducing an immune response to an Epstein Barr Virus (EBV) or methods of preventing infection of or reducing the likelihood of infection by an Epstein Barr Virus (EBV) using the compositions, or a combination of the EBV polypeptide and the liposomal adjuvant.
Need to check novelty before this filing date? Find Prior Art